Your browser doesn't support javascript.
loading
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.
Rytelewski, Mateusz; Tong, Jessica G; Buensuceso, Adrian; Leong, Hon S; Maleki Vareki, Saman; Figueredo, Rene; Di Cresce, Christine; Wu, Sherry Y; Herbrich, Shelley M; Baggerly, Keith A; Romanow, Larissa; Shepherd, Trevor; Deroo, Bonnie J; Sood, Anil K; Chambers, Ann F; Vincent, Mark; Ferguson, Peter J; Koropatnick, James.
Afiliação
  • Rytelewski M; Department of Microbiology and Immunology, Western University, London, Ontario, Canada.
  • Tong JG; Department of Anatomy and Cell Biology, Western University, London, Ontario, Canada.
  • Buensuceso A; Department of Biochemistry, Western University, London, Ontario, Canada.
  • Leong HS; Department of Surgery, Western University, London, Ontario, Canada.
  • Maleki Vareki S; Department of Microbiology and Immunology, Western University, London, Ontario, Canada.
  • Figueredo R; Department of Oncology, Western University, London, Ontario, Canada.
  • Di Cresce C; Department of Microbiology and Immunology, Western University, London, Ontario, Canada.
  • Wu SY; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Herbrich SM; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Baggerly KA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Romanow L; Department of Microbiology and Immunology, Western University, London, Ontario, Canada.
  • Shepherd T; Department of Anatomy and Cell Biology, Western University, London, Ontario, Canada.
  • Deroo BJ; Department of Biochemistry, Western University, London, Ontario, Canada.
  • Sood AK; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston,
  • Chambers AF; Department of Oncology, Western University, London, Ontario, Canada.
  • Vincent M; Department of Oncology, Western University, London, Ontario, Canada; Department of Pathology, Western University, London, Ontario, Canada.
  • Ferguson PJ; Department of Oncology, Western University, London, Ontario, Canada; Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada.
  • Koropatnick J; Department of Microbiology and Immunology, Western University, London, Ontario, Canada; Department of Oncology, Western University, London, Ontario, Canada; Department of Pathology, Western University, London, Ontario, Canada; Department of Physiology and Pharmacology, Western University, London, On
Mol Oncol ; 8(8): 1429-40, 2014 Dec.
Article em En | MEDLINE | ID: mdl-24974076
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Proteína BRCA2 Limite: Animals / Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Proteína BRCA2 Limite: Animals / Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá